Jack Joins the High Miles Club. Is AutoZone a Buy? | Barron's Streetwise

Key Concepts

• Auto Parts Retail: A sector benefiting from the aging of the U.S. vehicle fleet and the "consultant sale" model.
• "Amazon-proof" Business: Retail models that rely on in-store expertise and immediate service, making them resistant to e-commerce disruption.
• Healthcare Innovation: High-growth areas including GLP-1 weight-loss drugs, robotic-assisted surgery, and medical supply chain optimization.
• Valuation Disconnects: The phenomenon where stock prices underperform despite strong company fundamentals, often due to shifting market sentiment (e.g., the current focus on AI/chips).

---

The Auto Parts Industry: Resilience and Growth

The average age of vehicles on U.S. roads has reached 13 years, up from 9 years in 2000 and under 6 years in 1970. This trend is driven by higher new car prices (averaging over $50,000), the discontinuation of budget-friendly models, and improved vehicle build quality.

• Market Performance: AutoZone and O’Reilly have seen significant growth since 2020. AutoZone’s sales grew from $12.6 billion in 2020 to an estimated $20.5 billion.
• The "Buy the Dip" Thesis: Despite strong fundamentals, stocks like AutoZone have faced recent sell-offs. Analyst Michael Baker (D.A. Davidson) attributes this to a "disassociation" between company performance and stock price, driven by concerns that inflation-driven sales growth (which added 7 percentage points to recent quarters) will decelerate to roughly 4 percentage points.
• Resistance to E-commerce: Auto parts retailers are largely insulated from Amazon. Even with incentives (e.g., $20 off for home delivery), customers overwhelmingly prefer in-store pickup. This is because the business is a "consultant sale"—customers rely on store associates for technical advice, a service that cannot be replicated by online shipping.

---

Healthcare Innovation and Investment Opportunities

While the broader market has been driven by AI and chip stocks, the healthcare sector has lagged, trading at approximately 17 times forward earnings compared to the S&P 500’s 21–22 times. Shivani Vorra of Parnassus Investments highlighted several key players:

• Eli Lilly (LLY): Beyond its high-growth GLP-1 franchise, the company is reinvesting profits into drug discovery for Alzheimer’s, oncology, and mental health.
• Intuitive Surgical (ISRG): Known for the da Vinci surgical system, this company holds a near-monopoly. The system uses robotic arms to perform minimally invasive surgery through small incisions. It creates a "self-reinforcing ecosystem" where hospitals are locked in due to the high cost of the machines and the specialized training required for surgeons.
• Medline (MDLN): Described as the "Costco of healthcare," Medline focuses on high-margin, private-label medical supplies. They innovate by solving small, high-frequency pain points (e.g., redesigning surgical glove packaging to prevent waste), which creates "sticky" long-term contracts with hospitals.

---

Additional Healthcare Mentions

• Edwards Lifesciences (EW): Specializes in TAVR (transcatheter aortic valve replacement) and is expanding into TMTT (transcatheter mitral and tricuspid therapies), allowing for heart valve repair without open-heart surgery.
• Natera: A high-growth, pre-profit company focusing on non-invasive blood tests for prenatal screening and cancer treatment monitoring.

---

Synthesis and Conclusion

The podcast highlights a strategic shift in market focus. While investors are currently fixated on AI and infrastructure-related "tech" plays, there is significant value in "staple" industries like auto parts and healthcare.

The auto parts sector remains a robust, defensive play due to the aging vehicle fleet and the necessity of human expertise in the retail process. Simultaneously, the healthcare sector offers "on-sale" opportunities in companies that possess deep moats—whether through specialized robotic training (Intuitive Surgical) or essential, high-margin supply chain integration (Medline). The overarching takeaway is that investors should look for companies with strong, non-displaceable business models that are currently being overlooked by a market obsessed with the latest tech trends.